Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. CureVac N.V.
  6. News
  7. Summary
    CVAC   NL0015436031

CUREVAC N.V.

(CVAC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CureVac N : Deutsche Bank Starts CureVac at Hold with $35 Price Target

10/22/2021 | 10:54am EST


ę MT Newswires 2021
All news about CUREVAC N.V.
11:31aBerenberg Bank Adjusts CureVac Price Target to $52 From $70, Maintains Buy Rating
MT
01/21Health Care Stocks Retreat This Afternoon
MT
01/21Health Care Stocks Drifting Lower in Friday Trade
MT
01/21CureVac Shares Drop After BofA Securities Downgrade
MT
01/21BofA Securities Downgrades CureVac to Underperform From Neutral, Adjusts Price Target t..
MT
01/18CUREVAC N : Chief Technology Officer to Pursue New Career outside Biotech Industry - Form ..
PU
01/18JMP Securities Starts CureVac at Market Outperform With $52 Price Target
MT
01/18CureVac Technology Chief Mariola Fotin-Mleczek to Step Down
MT
01/17CureVac Chief Technology Officer to Pursue New Career outside Biotech Industry
EQ
01/17CureVac Announces Resignation of Mariola Fotin-Mleczek as Chief Technology Officer
CI
More news
Analyst Recommendations on CUREVAC N.V.
More recommendations
Financials
Sales 2021 70,4 M 78,4 M 78,4 M
Net income 2021 -540 M -602 M -602 M
Net cash 2021 899 M 1 002 M 1 002 M
P/E ratio 2021 -5,05x
Yield 2021 -
Capitalization 3 143 M 3 503 M 3 503 M
EV / Sales 2021 31,9x
EV / Sales 2022 36,1x
Nbr of Employees 505
Free-Float 44,9%
Chart CUREVAC N.V.
Duration : Period :
CureVac N.V. Technical Analysis Chart | CVAC | NL0015436031 | MarketScreener
Technical analysis trends CUREVAC N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 16,06 €
Average target price 35,40 €
Spread / Average Target 120%
EPS Revisions
Managers and Directors
Franz-Werner Haas Chief Executive Officer
Pierre Kemula Chief Financial Officer & Managing Director
Baron Jean StÚphenne Chairman-Supervisory Board
Mariola Fotin-Mleczek Chief Technology Officer
Igor Splawski Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
CUREVAC N.V.-51.33%3 503
MODERNA, INC.-41.48%60 258
LONZA GROUP AG-19.46%48 939
IQVIA HOLDINGS INC.-17.77%44 321
SEAGEN INC.-20.50%22 475
ICON PUBLIC LIMITED COMPANY-17.13%20 892